Hualan Biological EngineeringInc (002007) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Hualan Biological Engineering Inc., together with its subsidiaries, engages in the research, development, production, and sale of biological products in China and internationally.

Total Assets Chart for Hualan Biological EngineeringInc

Hualan Biological EngineeringInc (002007) total assets for FY2025 were CNY 15.3B, a -6.4% change from FY2024. Hualan Biological EngineeringInc's total assets grew from CNY 195.1M in 2001 to CNY 15.3B in 2025 (7722.2% over 24 years). Total assets compound annual growth rate: 5-year CAGR of 8.7%, 10-year CAGR of 14.3%, 20-year CAGR of 16.7%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (CNY)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
¥23.81B
Implied Share Price
¥13.04
Enterprise Value
¥21.06B
Revenue (TTM)
¥4.36B
EBITDA
¥1.23B
Profit Margin
18.52%
Trailing P/E
29.64
Forward P/E
24.57
Price/Book (MRQ)
2.16
Price/Sales (TTM)
5.46
EV/EBITDA
15.82
EV/Revenue
4.77
Dividend Yield
5.41%
Book Value
¥6.01
Free Cash Flow (FY2025)
¥944.67M
Free Cash Flow Yield
3.97%

Snapshot as of 4th September 2026 — not point-in-time controlled, may lag the live market by a few days.